
LYEL
Healthcare · Biotechnology · $351.6M market cap
$14.30-1.34 (-8.6%)Nov 13, 4:00 PM EST
Latest report
After the close
The next earnings date isn’t on the calendar yet.
Analyst consensus
Fiscal period ending Dec 31, 2026
EPS trend, 90 days to now · +2.5% over 90 days · 30-day revisions 1 up, 0 down
Beat estimates in 3 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Nov 4, 2026 | After the close | -2.06 | -1.86 | +9.7% |
| Aug 6, 2026 | After the close | -1.94 | -1.92 | +1.0% |
| May 6, 2026 | After the close | -2.36 | -1.10 | +53.4% |
| Mar 13, 2026 | Time not confirmed | -2.23 | -7.68 | -244.1% |
| Nov 12, 2025 | After the close | -2.64 | -2.13 | +19.3% |
| Aug 12, 2025 | After the close | -3.58 | -2.89 | +19.3% |
| May 13, 2025 | After the close | -3.60 | -3.60 | 0.0% |
| Mar 12, 2025 | Time not confirmed | -0.19 | -0.45 | -131.2% |
| Nov 7, 2024 | After the close | -4.00 | -3.40 | +15.0% |
| Aug 7, 2024 | After the close | -4.10 | -3.60 | +12.2% |
| May 6, 2024 | Time not confirmed | -0.24 | -0.24 | +0.3% |
| Feb 28, 2024 | After the close | -4.10 | -3.47 | +15.4% |
| Nov 7, 2023 | After the close | -4.60 |
Lyell Immunopharma, Inc., a clinical-stage cell therapy company, develops chimeric antigen receptor (CAR) T-cell product candidates for patients with hematologic malignancies and solid tumors. The company's lead product candidate include rondecabtagene autoleucel, an autologous dual-targeting CD19/CD20 CAR T-cell therapy in development, which is in pivotal PiNACLE trial in the 3L+ setting and in a Phase 1/2…
| -3.43 |
| +25.4% |
| Aug 8, 2023 | After the close | -4.50 | -3.65 | +18.9% |
| May 4, 2023 | After the close | -4.40 | -3.59 | +18.4% |
| Feb 28, 2023 | After the close | -0.30 | -0.04 | +86.7% |
| Nov 8, 2022 | After the close | -6.60 | -3.52 | +46.7% |
| Aug 4, 2022 | After the close | -5.50 | -0.84 | +84.7% |
| May 10, 2022 | After the close | -5.20 | -4.09 | +21.3% |
| Mar 29, 2022 | After the close | -0.28 | -0.35 | -25.0% |
| Nov 12, 2021 | Before the open | -10.37 | -2.98 | +71.3% |
| Aug 12, 2021 | After the close | -17.40 | -17.83 | -2.5% |
| Jun 18, 2021 | After the close | 0.00 | -0.84 | — |
| Mar 31, 2021 | Time not confirmed | 0.00 | -3.19 | — |
| Mar 31, 2020 | Time not confirmed | 0.00 | -2.82 | — |